Phase II Trial of Non-Myeloablative Conditioning and Partially HLA-Mismatched (HLA-Haploidentical) Bone Marrow Transplantation (BMT) for Patients With Hematologic Malignancies: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0603
2011 ◽
Vol 17
(2)
◽
pp. S151
◽
2016 ◽
Vol 22
(3)
◽
pp. S104
◽
2011 ◽
Vol 17
(2)
◽
pp. S151
◽
2013 ◽
Vol 19
(1)
◽
pp. 117-122
◽
1998 ◽
Vol 102
(3)
◽
pp. 647-655
◽
2018 ◽
Vol 24
(4)
◽
pp. 700-707
◽
1996 ◽
Vol 93
(1)
◽
pp. 131-138
◽
1996 ◽
Vol 14
(9)
◽
pp. 2454-2464
◽